|[June 24, 2014]
CORE Diagnostics Appoints New CEO to Accelerate Growth
PALO ALTO, Calif. --(Business Wire)--
CORE Diagnostics, Inc., the leading high-end clinical diagnostics
laboratory, announced today the appointment of K. Balachandran (Bala) as
chief executive officer, effective immediately.
With more than 25 years of experience with large publicly traded
companies both domestically and internationally, Bala brings to CORE
hands-on knowledge of the healthcare industry and the high-tech sector.
Most recently, Bala served as the chief operating officer of NeuroMetrix,
Inc., where he successfully transitioned the company's strategic
direction to point-of-care diabetic neuropathy and put the company on a
growth trajectory. Previously, after 8 years with HP in various program
management and P&L roles based in California, including director of the
company's strategic alliances, he joined Cardinal Health as vice
president and general manager of the NeuroCare business division and
oversaw a global P&L of $150 million. Pior to that, Bala was a leader
at Nicolet Biomedical in Madison, Wis., as the director for the Asia
Pacific business and advanced to become vice president of Nicolet's
"Bala's intimate knowledge of the healthcare industry, customer focus
and P&L experience coupled with his track record in developing
international markets are an excellent fit with our needs," said Dr.
Ajit Singh, managing director and general partner at Artiman Ventures,
and chairman of the board of CORE Diagnostics. "We are very pleased to
have him on board and look forward to his contributions as we continue
developing CORE Diagnostics into a premier clinical pathology laboratory
and contract research organization."
CORE Diagnostics is focused on bringing the most advanced testing
techniques and expertise to routine clinical practice. The company
offers a rich menu of high-end tests and provides patients with peace of
mind by delivering second opinions on every test from at least two
specialists from its global panel of pathologists.
"It is a great privilege to lead the extremely talented people at CORE
Diagnostics at such a time when the company is positioned for growth,
both in its clinical pathology biopharma research initiatives globally,"
said K. Balachandran, CEO at CORE Diagnostics.
ABOUT CORE DIAGNOSTICS
CORE Diagnostics is a clinical laboratory offering next generation
diagnostics for disease stratification and therapy selection. With
offices in Palo Alto, CA (News - Alert), and Gurgaon, India, CORE Diagnostics offers a
comprehensive menu of specialized, advanced diagnostic testing in the
areas of cardiology, oncology, reproductive disorders, endocrinology and
infectious diseases. The company also deploys next generation sequencing
in clinical applications and uses digital pathology for enabling
concurrent global review of test results. CORE Diagnostics is backed by
Artiman Ventures, the leading white space investment firm based in Palo
Alto, Calif. For more information, please visit www.corediagnostics.in.
[ InfoTech Spotlight's Homepage ]